Clinical research agreements (CRAs) and developing a regulatory strategy—particularly in connection with the Food and Drug Administration ...
Capricor Therapeutics (CAPR) announced long-term data from its ongoing HOPE-2 open label extension clinical trial, demonstrating the potential ...
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...
Tv Therapeutics said that the U.S. FDA has lifted the clinical hold on the cadisegliatin clinical program, including late ...
Researchers at the University of Toronto and University of Calgary have developed an innovative approach that uses artificial ...
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results